CDK5 and Alzheimer disease: These studies suggest that knock-in mice, which are resistant to the phosphorylation of CRMP2 by the kinases Cdk5 and GSK-3β that are activated in AD, show resilience to cognitive impairment caused by Aβ25–35 oligomers.